[1]姚 峰,何思泉,王妹芳,等.急性冠状动脉综合征患者经皮冠状动脉介入术后支架再狭窄与血浆内皮细胞膜微粒的相关性[J].新乡医学院学报,2021,38(3):245-248.[doi:10.7683/xxyxyxb.2021.03.008]
 YAO Feng,HE Siquan,WANG Meifang,et al.Correlation between plasma endothelial microparticles and stent restenosis after percutaneous coronary intervention of patients with acute coronary syndrome[J].Journal of Xinxiang Medical University,2021,38(3):245-248.[doi:10.7683/xxyxyxb.2021.03.008]
点击复制

急性冠状动脉综合征患者经皮冠状动脉介入术后支架再狭窄与血浆内皮细胞膜微粒的相关性
分享到:

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
38
期数:
2021年3
页码:
245-248
栏目:
临床研究
出版日期:
2021-03-05

文章信息/Info

Title:
Correlation between plasma endothelial microparticles and stent restenosis after percutaneous coronary intervention of patients with acute coronary syndrome
作者:
姚 峰1何思泉2王妹芳1肖梦媛1李 波1
(1.广东医科大学附属医院心血管内科,广东 湛江 524000;2.广东医科大学附属第二医院心血管内科,广东 湛江 524000)
Author(s):
YAO Feng1HE Siquan2WANG Meifang1XIAO Mengyuan1LI Bo1
(1.Department of Cardiovascular Medicine,Affiliated Hospital of Guangdong Medical University,Zhanjiang 524000,Guangdong Province,China2.Department of Cardiovascular Medicine,the Second Affiliated Hospital of Guangdong Medical University,Zhanjiang 524000,Guangdong Province,China)
关键词:
急性冠状动脉综合征经皮冠状动脉介入术支架内再狭窄内皮细胞膜微粒白细胞介素-6细胞间黏附分子-1
Keywords:
acute coronary syndromepercutaneous coronary interventionstent restenosisendothelial microparticlesinterleukin-6intercellular adhesion molecule-1
分类号:
R256.2
DOI:
10.7683/xxyxyxb.2021.03.008
文献标志码:
A
摘要:
目的 探讨血浆内皮细胞膜微粒(EMPs)、血清白细胞介素-6(IL-6)和细胞间黏附分子-1(ICAM-1)与急性冠状动脉综合征患者经皮冠状动脉介入术(PCI)后支架再狭窄的相关性。方法 回顾性分析2016年5月至2018年11月广东医科大学附属医院收治的200例急性冠状动脉综合征患者的临床资料,患者均顺利完成PCI手术。术后1 a对患者进行冠状动脉造影,根据PCI术后是否出现支架再狭窄分为再狭窄组(n=36)和非狭窄组(n=164),并对再狭窄组患者的狭窄程度进行分级。分别于PCI术前1 h及术后1 d、1周、1个月、6个月、1 a,采用酶联免疫吸附试验检测2组患者血清IL-6、ICAM-1水平;流式细胞仪检测2组患者血浆EMPs水平。分析血清IL-6、ICAM-1水平与血浆EMPs水平的相关性及血浆EMPs水平与急性冠状动脉综合征患者PCI术后支架再狭窄的相关性。结果 PCI术前及术后1 d,再狭窄组和非狭窄组患者血清IL-6、ICAM-1及血浆EMPs水平比较差异均无统计学意义(P>0.05);术后1周、1个月、6个月、1 a,再狭窄组患者血清IL-6、ICAM-1及血浆EMPs水平高于非狭窄组(P<0.05)。术后1 a,再狭窄组患者中血管狭窄A级31例(86.11%),B级3例(8.33%),O级2例(5.56%)。急性冠状动脉综合征患者PCI术后血清IL-6、ICAM-1水平均与血浆EMPs呈正相关(r=0.033、0.530,P<0.05)。急性冠状动脉综合征患者PCI术后血浆EMPs水平与支架再狭窄的发生呈正相关(r=0.658,P<0.05)。结论 急性冠状动脉综合征患者PCI术后血清IL-6、ICAM-1及血浆EMPs水平均升高,血浆EMPs水平与PCI术后支架再狭窄的发生有关。
Abstract:
Objective To investigate the correlation between the plasma endothelial microparticles (EMPs),serum interleukin-6 (IL-6) and intercellular adhesion molecule-1 (ICAM-1) and stent restenosis after percutaneous coronary intervention (PCI) of patients with acute coronary syndrome.Methods  The clinical data of 200 patients with acute coronary syndrome admitted to the Affiliated Hospital of Guangdong Medical University from May 2016 to November 2018 was retrospectively analyzed.All the patients successfully completed PCI.All patients were evaluated for coronary arteryangiography at 1 a after operation,and they were divided into restenosis group (n=36) and non-stenosis group (n=164) according to whether stent restenosis occurred after PCI,and the degree of restenosis of patients in the restenosis group was graded.The serum IL-6,ICAM-1 levels were detected at 1 h before PCI and 1 d,1 week,1 month,6 months,1 year after PCI.The plasma EMPs levels were measured by flow cytometry in both groups.The correlation between serum IL-6,ICAM-1 levels and plasma EMPs levels and the correlation between plasma EMPs levels and stent restenosis of patients with acute coronary syndrome after PCI were analyzed.Results There was no significant difference in serum IL-6,ICAM-1 and plasma EMPs levels of patients between the restenosis group and the non-stenotic group before and 1 d after surgery (P>0.05);the serum levels of IL-6,ICAM-1 and plasma EMPs levels of patients in the restenosis group were higher than those in the non-stenosis group at 1 week,1 month,6 months and 1 year after operation(P<0.05).In the restenosis group,31 cases (86.11%) were grade A,3 cases (8.33%) were grade B and 2 cases (5.56%) were grade O.The serum levels of IL-6 and ICAM-1 of patients with acute coronary syndrome after PCI were positively correlated with the level of EMPs (r=0.033,0.530;P<0.05).The plasma EMPs level of patients with acute coronary syndrome after PCI was positively correlated with the occurrence of stent restenosis (r=0.658,P<0.05).Conclusion The serum levels of IL-6,ICAM-1 and the plasma levels of EMPs in patients with acute coronary syndrome after PCI increase and the plasma levels of EMPs are positively correlated with the occurrence of stent restenosis.

参考文献/References:

[1] KIM J W,KANG H J,BAE K Y,et al.Social support deficit and depression treatment outcomes in patients with acute coronary syndrome:findings from the EsDEPACS study[J].Int J Psychiatry Med,2019,54(1):39-52.
[2] 王宇平,郭金成,苏平,等.银杏酮酯联合常规抗血小板方案在急性冠脉综合征患者经皮冠脉介入术后氯吡格雷抵抗的应用价值[J].世界中医药,2019,14(7):1892-1897.
[3] 林欣,杨滨,王晔玲,等.冠脉支架植入术后炎症反应对再狭窄影响的研究进展[J].中国老年学杂志,2019,39(1):233-236.
[4] 彭芝萍,余洋,朱雯雯,等.通心络胶囊对急性心肌梗死患者PCI术后血清EMPs及MMP-9的影响[J].现代中西医结合杂志,2017,26(28):3117-3119.
[5] 张辉,王宁.益气活血中药对急性冠脉综合征患者经皮冠状动脉介入术后左室重构及心功能的影响[J].世界中医药,2017,12(12):2984-2987,2991.
[6] 徐军伟,卢芳,钱跃磊,等.灯盏生脉胶囊联合替格瑞洛用于急性心肌梗死经皮冠状动脉介入术后的疗效及对患者凝血功能的影响[J].新乡医学院学报,2020,37(7):622-625.
[7] 索旻,聂绍平,赵雪东,等.急性ST段抬高型心肌梗死急诊经皮冠状动脉支架术后支架内再狭窄相关因素分析[J].心肺血管病杂志,2019,38(4):344-347.
[8] 阎志,邢小卫,刘玉胜,等.冠心病患者PCI术后冠状动脉药物支架内再狭窄的危险因素分析[J].山东医药,2019,59(17):47-50.
[9] 张明明.应用抗生素可降低经皮冠状动脉介入术后复发风险[J].河南大学学报(医学版),2018,37(4):265-268.
[10] ZHANG C J,DENG Y Z,LEI Y H,et al.The mechanism of exogenous adiponectin in the prevention of no-reflow phenomenon in type 2 diabetic patients with acute myocardial infarction during PCI treatment[J].Eur Rev Med Pharmacol Sci,2018,22(7):2169-2174.
[11] 赵艳平,万艳娜,王国荣,等.IL-6、TNF-α、MMP-9表达水平与股动脉支架植入后再狭窄的相关性分析[J].中国医学创新,2019,16(31):34-38.
[12] 周庆娜,林文华,敬锐,等.心外膜脂肪组织容积及炎症因子对支架置入术后支架内再狭窄的预测价值[J].中华医学杂志,2019,99(47):3732-3736.
[13] 毛庆,梁秀琳,周学中,等.血清谷氨酰转移酶水平与支架内再狭窄患者炎症反应及血管新生的关系[J].中国循证心血管医学杂志,2018,10(11):1318-1321.
[14] 王力,李志国,刘艳,等.血清S1P、Adropin水平对脑血管支架植入术后再狭窄的预测价值及其与血管活性物质、细胞因子的关系[J].海南医学院学报,2017,23(11):1516-1519.
[15] 刘雨东,何金孝,吴华杰,等.miR-133a-5p通过靶向细胞间黏附分子1对脂多糖诱导的肺泡上皮细胞A549损伤的影响[J].中华实用儿科临床杂志,2020,35(16):1239-1243.
[16] 李永慧,王小玲,张玲玲,等.强化剂量瑞舒伐他汀联合替格瑞洛对急性冠脉综合征患者术后心功能及ICAM-1、TIMP-1水平的影响[J].中国医师杂志,2019,21(10):1523-1526.
[17] 梁晶,王紫监,张子立,等.丹红注射液对ACS病人PCI术后炎性因子、细胞黏附分子及内皮功能的影响[J].中西医结合心脑血管病杂志,2019,17(10):1535-1538.
[18] 刘学武,张遐智,张芳兰,等.急性心肌梗死患者介入治疗后口服通心络胶囊对血清内皮细胞微粒及基质金属蛋白酶9水平的影响[J].中国药物警戒,2017,14(3):142-144,149.
[19] BERNAL-MIZRACHI L,JY W,JIMENEZ J J,et al.High levels of circulating endothelial microparticles in patients with acute coronary syndromes[J].Am Heart J,2003,145(6):962-970.
[20] JY W,MINAGAR A,JIMENEZ J J,et al.Endothelial microparticles (EMP) bind and activate monocytes:elevated EMP-monocyte conjugates in multiple sclerosis[J].Front Biosci,2004,9(1):3137-3144.
[21] NISHIO K,SAKURAI M,KUSUYAMA T,et al.A randomized comparison of pioglitazone to inhibit restenosis after coronary stenting in patients with type 2 diabetes[J].Diabetes Care,2006,29(1):101-106.
[22] 陆永光,李浪,苏强,等.急性冠脉综合征患者内皮细胞微粒与CD4+CD25+Foxp3+调节性T细胞的关系[J].吉林大学学报(医学版),2016,42(5):963-967.

相似文献/References:

[1]陈雪斌,马利平,王秋芬.替罗非班治疗高危非ST 段抬高急性冠状动脉综合征的疗效及对血浆脑钠肽含量的影响[J].新乡医学院学报,2010,(06):579.
[2]王志华,黄佐.辛伐他汀与血脂康用于高龄急性冠状动脉综合征患者调脂治疗的临床观察[J].新乡医学院学报,2012,(07):532.
[3]周利霞.不同剂量瑞舒伐他汀治疗急性冠状动脉综合征临床分析[J].新乡医学院学报,2016,(05):397.[doi:10.7683/xxyxyxb.2016.05.014]
[4]詹小娜,包恩泽,李贵华,等.替格瑞洛联合小剂量替罗非班对行急诊经皮冠状动脉介入术老年急性ST段抬高型心肌梗死患者梗死相关动脉血流及主要不良心血管事件的影响[J].新乡医学院学报,2018,35(7):584.[doi:10.7683/xxyxyxb.2018.07.009.]
 ZHAN Xiao-na,BAO En-ze,LI Gui-hua,et al.Effect of ticagrelor combined with low dose tlrofiban on infarction artery blood flow & major adverse cardiovascular events elder patients with acute ST elevated myocardial infarction undergoing emerg[J].Journal of Xinxiang Medical University,2018,35(3):584.[doi:10.7683/xxyxyxb.2018.07.009.]
[5]崔 建.瑞舒伐他汀对不稳定型心绞痛患者经皮冠状动脉介入术后心肌损伤的保护作用[J].新乡医学院学报,2014,(12):1042.[doi:10.7683/xxyxyxb.2014.12.023]
[6]易 华,辛 娟,彭 红,等.高强度间歇训练对急性心肌梗死患者经皮冠状动脉介入术后心脏康复的影响[J].新乡医学院学报,2021,38(7):645.[doi:10.7683/xxyxyxb.2021.07.009]
 YI Hua,XIN Juan,PENG Hong,et al.Effect of high-intensity intermittent training on the cardiac rehabilitation in patients with acute myocardial infarction after percutaneous coronary intervention[J].Journal of Xinxiang Medical University,2021,38(3):645.[doi:10.7683/xxyxyxb.2021.07.009]
[7]栾 一,杨吉操.美托洛尔联合西洛他唑在急性心肌梗死患者经皮冠状动脉介入术后的应用价值[J].新乡医学院学报,2021,38(7):619.[doi:10.7683/xxyxyxb.2021.07.004]
 LUAN Yi,YANG Jicao.Application value of metoprolol combined with cilostazol in patients with acute myocardial infarction after percutaneous coronary intervention[J].Journal of Xinxiang Medical University,2021,38(3):619.[doi:10.7683/xxyxyxb.2021.07.004]
[8]徐军伟,卢 芳,钱跃磊,等.灯盏生脉胶囊联合替格瑞洛用于急性心肌梗死经皮冠状动脉介入术后的疗效及对患者凝血功能的影响[J].新乡医学院学报,2020,37(7):622.[doi:10.7683/xxyxyxb.2020.07.005.]
 XU Junwei,LU Fang,QIAN Yuelei,et al.Therapeutic effect of Dengzhan Shengmai capsule combined with ticagrelor in treatment of acute myocardial infarction after percutaneous coronary intervention and its effect on coagulation function of patients[J].Journal of Xinxiang Medical University,2020,37(3):622.[doi:10.7683/xxyxyxb.2020.07.005.]
[9]胡志良.糖化血红蛋白水平对2型糖尿病伴急性心肌梗死患者经皮冠状动脉介入术预后及支架内再狭窄程度的影响[J].新乡医学院学报,2019,36(12):1159.[doi:10.7683/xxyxyxb.2019.12.014.]
 HU Zhi-liang.Effects of glycosylated hemoglobin level on the prognosis of patients with type 2 diabetes mellitus with acute myocardial infarction after percutaneous coronary intervention and the degree of stent restenosis[J].Journal of Xinxiang Medical University,2019,36(3):1159.[doi:10.7683/xxyxyxb.2019.12.014.]
[10]陈瑞阳.双倍剂量氯吡格雷对心肌梗死患者经皮冠状动脉介入术后氯吡格雷抵抗的影响[J].新乡医学院学报,2018,35(8):716.[doi:10.7683/xxyxyxb.2018.08.017.]
 CHEN Rui-yang.Effect of double dose of clopidogrel on clopidogrel resistance after percutaneous coronary intervention in patients with myocardial infarction[J].Journal of Xinxiang Medical University,2018,35(3):716.[doi:10.7683/xxyxyxb.2018.08.017.]

更新日期/Last Update: 2021-03-05